Independence Capital Asset Partners’s Celgene Corp CELG Stock Holding History

Independence Capital Asset Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-207,827	Closed	-$23.2M	–	118
2014 Q4	$23.2M	Sell	207,827 -17,847	-8%	-$1.88M	3.21%	7
2014 Q3	$21.4M	Buy	225,674 +60,872	+37%	+$5.49M	2.99%	7
2014 Q2	$14.2M	Sell	164,802 -3,390	-2%	-$258K	1.94%	24
2014 Q1	$11.7M	Sell	168,192 -162,420	-49%	-$12.9M	1.95%	20
2013 Q4	$27.9M	Buy	330,612 +10,876	+3%	+$861K	4.25%	3
2013 Q3	$24.6M	Buy	319,736 +88,592	+38%	+$6.21M	4.19%	3
2013 Q2	$13.5M	Buy	+231,144	New	+$13.9M	2.35%	10

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Independence Capital Asset Partners's CELG Position: Q1 2015 in Review

Independence Capital Asset Partners sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 207,827 shares — an estimated $23.2M sold.

Independence Capital Asset Partners first reported a position in CELG in Q2 2013 and held it in 7 quarters. The position peaked at $27.9M in Q4 2013. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

Independence Capital Asset Partners reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
Independence Capital Asset Partners sold 207,827 Celgene Corp shares in Q1 2015, an estimated $23.2M.
Independence Capital Asset Partners first reported a position in Celgene Corp in Q2 2013 and held it in 7 quarters.
Independence Capital Asset Partners's Celgene Corp position peaked at $27.9M in Q4 2013.
1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Independence Capital Asset Partners's 13F filing for Q1 2015, filed 14 May 2015.